Cancer surgery is the use of an operative procedure to remove, destroy, examine or otherwise manage cancerous tissue. It is one of the principal modalities of cancer treatment and is particularly important for solid tumours that are confined to one anatomical region. The National Cancer Institute describes cancer surgery as a procedure in which a surgeon removes cancer from the body. Surgery can be performed with curative intent, to remove all visible cancer, or with other objectives when complete removal is not possible. Its role depends on the cancer type, stage, location, biological behaviour and overall treatment plan.
The most familiar form is resection, in which the surgeon removes the tumour together with an appropriate margin of surrounding tissue. The margin is intended to reduce the probability that microscopic cancer cells remain at the edge of the removed specimen. Depending on the disease, surgeons may also remove nearby lymph nodes to determine whether cancer has spread or to reduce regional disease. Surgery can involve minimally invasive techniques, including laparoscopic or robotic approaches, or conventional open surgery involving a larger incision. The choice depends on tumour anatomy, accessibility, required precision, previous operations and the surgeon's ability to achieve the necessary oncological result safely.
Surgery has several distinct purposes. Curative surgery attempts to remove all cancer that can be identified and is most useful when disease is localised or otherwise surgically controllable. Debulking, or cytoreductive surgery, removes part rather than all of a tumour when complete removal would cause unacceptable damage or is technically impossible. Palliative surgery aims to relieve symptoms caused by cancer, such as obstruction, bleeding, pressure or pain, without necessarily eliminating the underlying malignancy. Diagnostic surgery can obtain tissue for pathological examination, although many modern diagnoses are made using needle biopsy or other less invasive techniques. These purposes should not be confused because they imply different expectations and treatment goals.
Cancer surgery is frequently combined with other treatments. Neoadjuvant chemotherapy, radiotherapy, targeted therapy or immunotherapy may be given before an operation to shrink a tumour, make resection easier or treat microscopic disease elsewhere in the body. Adjuvant treatment may be given after surgery to reduce the risk of recurrence by addressing cancer cells that cannot be seen or removed surgically. Surgery therefore often forms one component of multimodal cancer treatment rather than functioning as an isolated intervention. The appropriate sequence depends on tumour biology, stage, molecular characteristics, anatomical location and evidence from clinical trials.
Surgical cancer treatment requires careful consideration of anatomy and the relationship between tumour removal and preservation of normal function. Depending on location, an operation may involve removal of part of an organ, an entire organ, adjacent tissues or regional lymph nodes. Surgeons aim to achieve adequate cancer clearance while preserving as much normal tissue and function as reasonably possible.
Modern surgical oncology also uses pathological assessment of margins and lymph nodes to establish whether the removed specimen contains cancer at its edges or evidence of regional spread. These findings can influence staging, prognosis and the decision about additional treatment. Consequently, the operation itself and the laboratory analysis of the specimen are closely connected.
Surgery carries risks that depend heavily on the procedure and the person's health. Common risks include postoperative pain, infection, bleeding, blood clots, injury to nearby structures and complications related to anaesthesia. The extent of tissue removal can also produce organ-specific functional consequences, such as altered digestion, changes in urinary or sexual function, impaired mobility or the need for reconstructive procedures. Recovery may involve hospitalisation, wound care, rehabilitation, physiotherapy, nutritional support or temporary restrictions on activity. The National Cancer Institute emphasises that pain and infection are common potential postoperative problems, while bleeding, damage to nearby tissues and anaesthetic reactions are additional risks.
Cancer surgery has developed substantially from the extensive operations historically used when cancer was treated primarily through radical anatomical removal. Improvements in imaging, pathology, anaesthesia, intensive care, minimally invasive surgery and multidisciplinary cancer planning have enabled more selective procedures in many settings. Sentinel lymph-node techniques can sometimes identify the first draining lymph nodes likely to contain metastatic cells, potentially avoiding unnecessary removal of larger groups of nodes. Image guidance and robotic or laparoscopic technology can improve access to difficult anatomical regions in selected operations. Nevertheless, technological sophistication does not automatically make an operation appropriate; oncological effectiveness, safety and preservation of function remain central considerations.
An important misconception is that surgery is automatically curative or that finding cancer elsewhere after surgery means the operation “failed”. Surgery can remove a known tumour effectively while microscopic cancer cells elsewhere remain undetectable, which is why systemic treatments may be necessary. Conversely, surgery is not appropriate for every cancer: blood cancers such as leukaemia generally involve widespread abnormal blood-forming cells rather than one removable solid mass, although surgery can still have specific diagnostic or supportive roles. Whether surgery is beneficial depends on stage, resectability, tumour biology and the balance between expected benefit and operative harm. Decisions are therefore normally made within a multidisciplinary cancer team using pathology, imaging and other clinical information.
